Literature DB >> 31974196

Clinical and laboratory characteristics of cyclic thrombocytopenia: an observational study.

Oskar Steinbrecher1, Mirjana Mitrovic2,3, Lisbeth Eischer1, Hana Šinkovec4, Sabine Eichinger1,5, Paul A Kyrle6,5.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31974196      PMCID： PMC7109752          DOI： 10.3324/haematol.2019.237909

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Cyclic thrombocytopenia and polycythemia vera.

Authors:  K Kojima; N Fujii; E Omoto; S Nose; M Yoneyama; Y Sugii; H Hiramatsu; M Chikatsune; M Sato; S Takata; T Itoshima; M Tanimoto
Journal:  Ann Hematol       Date:  2002-12-06       Impact factor: 3.673

2.  Cyclic thrombocytopenia associated with marked rebound thrombocytosis and fluctuating levels of endogenous thrombopoietin and reticulated platelets: a case report.

Authors:  David Ewan Connor; Joanne Emily Joseph
Journal:  Am J Hematol       Date:  2011-10-31       Impact factor: 10.047

Review 3.  Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.

Authors:  C Haurie; D C Dale; M C Mackey
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

4.  Clonal T cell-mediated cyclic thrombocytopenia.

Authors:  Wolfgang Füreder; Gerlinde Mitterbauer; Renate Thalhammer; Klaus Geissler; Simon Panzer; Michael Krebs; Ingrig Simonitsch-Klupp; Wolfgang R Sperr; Klaus Lechner; Paul A Kyrle
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

5.  Large granular lymphocytic proliferation-associated cyclic thrombocytopenia.

Authors:  Patrick F Fogarty; Maryalice Stetler-Stevenson; Aloysius Pereira; Cynthia E Dunbar
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

6.  Cyclic thrombocytopenia successfully treated with low dose hormonal contraception.

Authors:  C Helleberg; E Taaning; P B Hansen
Journal:  Am J Hematol       Date:  1995-01       Impact factor: 10.047

7.  Danazol therapy in cyclic acquired amegakaryocytic thrombocytopenic purpura: a case report.

Authors:  R Kashyap; V P Choudhry; H P Pati
Journal:  Am J Hematol       Date:  1999-03       Impact factor: 10.047

Review 8.  LGL leukemia: from pathogenesis to treatment.

Authors:  Thierry Lamy; Aline Moignet; Thomas P Loughran
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

9.  Cyclic thrombocytopenia in a patient treated with cyclosporine for refractory idiopathic thrombocytopenic purpura.

Authors:  T Shirota; H Yamamoto; H Fujimoto; Y Harada; K Okada; H Uchida; H Roppongi; T Hayashi
Journal:  Am J Hematol       Date:  1997-12       Impact factor: 10.047

10.  Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function.

Authors:  C L Balduini; C C Stella; V Rosti; G Bertolino; P Noris; E Ascari
Journal:  Br J Haematol       Date:  1993-12       Impact factor: 6.998
View more
  2 in total

1.  Cyclical Thrombocytopenia Synchronized With the Patient's Menstrual Cycle Treated With Danazol.

Authors:  Sasmith R Menakuru; Adelina Priscu; Vijaypal Dhillon; Ahmed Salih
Journal:  J Hematol       Date:  2022-03-12

2.  Cyclic Thrombocytopenia: A Rare Cause of Recurrent Thrombocytopenia.

Authors:  Mosunmoluwa Oyenuga; Afoma Onyechi; Sara Sartaj; Rushin Patel; Jyotsana Sinha
Journal:  Cureus       Date:  2022-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.